Ayman Chit

University of Toronto
Drug Development and Disease Diagnostics Health Services Research

Research Interests:

Ayman Chit’s research focuses on three main areas: 1) The epidemiology of infectious diseases; 2) the effectiveness and cost-effectiveness of health technologies and interventions with a special focus on vaccines; 3) the economics of the healthcare system with a focus on the discovery, development and implementation of health technologies.

Brief Bio:

Ayman’s research aims to determine the incidence and burden of infectious diseases globally—in both developed and developing countries. He also works on determining the effectiveness of various vaccines through studying immunization programs and their effects on populations and health systems. In addition, Ayman studies healthcare system structure and the economic incentives related to drug and vaccine use, as well as the economics of the drug and vaccine development process. In all three areas of his research, Ayman uses randomized clinical trials, observational studies and mathematical models. The findings from his studies provide valuable disease statistics, inform whether new vaccines should be adopted in healthcare practice, and inform the development of policy mechanisms to improve drug development and adoption.

 Ayman Chit

University of Toronto
Drug Development and Disease Diagnostics Health Services Research

Research Interests:

Ayman Chit’s research focuses on three main areas: 1) The epidemiology of infectious diseases; 2) the effectiveness and cost-effectiveness of health technologies and interventions with a special focus on vaccines; 3) the economics of the healthcare system with a focus on the discovery, development and implementation of health technologies.

Brief Bio:

Ayman’s research aims to determine the incidence and burden of infectious diseases globally—in both developed and developing countries. He also works on determining the effectiveness of various vaccines through studying immunization programs and their effects on populations and health systems. In addition, Ayman studies healthcare system structure and the economic incentives related to drug and vaccine use, as well as the economics of the drug and vaccine development process. In all three areas of his research, Ayman uses randomized clinical trials, observational studies and mathematical models. The findings from his studies provide valuable disease statistics, inform whether new vaccines should be adopted in healthcare practice, and inform the development of policy mechanisms to improve drug development and adoption.